To include your compound in the COVID-19 Resource Center, submit it here.

Novartis halts price increases, reports 2Q earnings

Novartis AG (NYSE:NVS; SIX:NOVN) announced on July 18 that it will suspend for the rest of the year price increases in the U.S.

The pharma made the announcement in conjunction with the release of its 2Q18 earnings.

On the company’s earnings conference call, CEO Vas Narasimhan said Novartis made the decision based on

Read the full 522 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers